Last updated on July 2018

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Brief description of study

Study of effects of secukinumab 300 mg s.c. on quality of life (QoL) in psoriasis patients with or without prior exposure to systemic therapy.

Clinical Study Identifier: NCT02752776

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Vechta, Germany